Las Vegas, NV -- (SBWIRE) -- 02/01/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by http://beststocksdaily.com/
Ibio Inc(NYSEAMEX:IBIO) fell 1.47% and is trading at $0.670. iBio, Inc. (iBio) is a biotechnology company focused on commercializing its technologies, the iBioLaunch platform for vaccines and therapeutic proteins, as well as the iBioModulator platform for vaccine enhancement. Vaccine candidates on its platform are applicable to newly emerging strains of hemagglutinin type 1 and neuraminidase type 1 (H1N1), swine-like influenza, hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza, yellow fever, and anthrax.
Can IBIO Continues To Move Higher Back? Find Out Here http://beststocksdaily.com/p2/index.php?company=IBIO
Cover-All Technologies Inc.(NYSEAMEX:COVR) is lower 2.86% and is trading at $1.36. Cover-All Technologies Inc. provides business-focused solutions to the property and casualty insurance industry. The Company's customers include insurance companies, agents, brokers and managing general agents (MGAs). In addition, the Company also offers a Business Intelligence suite of products to enable its customers to leverage their information assets for real time business insights and for risk selection, pricing and financial reporting.
Get Free Trend Analysis on COVR Here http://beststocksdaily.com/p2/index.php?company=COVR
Park City Group, Inc.(NYSEAMEX:PCYG) fell 0.59% and is trading at $3.38. Park City Group, Inc. is a Software-as-a-Service (SaaS) provider. The Company's services are delivered principally though software products designed, developed, marketed and supported by the Company. The Company develops and offers its software to supermarkets, convenience stores and other retailers.
To Get complete technical analysis on PCYG go to http://beststocksdaily.com/p2/index.php?company=PCYG
PROLOR Biotech Inc(NYSEAMEX:PBTH) is higher 1.06% and is trading at $4.75. PROLOR Biotech, Inc. (Prolor) is a development-stage biopharmaceutical company, utilizing technology to develop longer-acting, versions of therapeutic proteins. The Company is using the carboxyl terminal peptide (CTP) technology to develop new versions of certain therapeutic proteins.
Get Free Trend Analysis on PBTH Here http://beststocksdaily.com/p2/index.php?company=PBTH
Protalix BioTherapeutics Inc.(NYSEAMEX:PLX) added 1.17% and is trading at $5.17. Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action.
To Get complete technical analysis on PLX go to http://beststocksdaily.com/p2/index.php?company=PLX
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)